Please Wait
Applying Filters...
menu
    • menu
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma CDMO offers integrated end-to-end solutions for development & commercialization of intermediates & APIs for small molecules.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    veranova-m-2025-06-30

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Left Arrow
    Right Arrow

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    TORL BioTherapeutics LLC is a dynamic clinical-stage biopharmaceutical company dedicated to pioneering novel, antibody-based therapeutics with the aim of revolutionizing cancer treatment and improving patient outcomes. Our lead candidate, TORL-1-23, is an antibody-drug conjugate (ADC) directed against CLDN6, designed to benefit patients across various cancer types. Additionally, we have two other clinical-stage programs, inclu...
    TORL BioTherapeutics LLC is a dynamic clinical-stage biopharmaceutical company dedicated to pioneering novel, antibody-based therapeutics with the aim of revolutionizing cancer treatment and improving patient outcomes. Our lead candidate, TORL-1-23, is an antibody-drug conjugate (ADC) directed against CLDN6, designed to benefit patients across various cancer types. Additionally, we have two other clinical-stage programs, including an ADC and a monoclonal antibody (mAb) targeting CLDN 18.2. TORL is actively developing a diverse pipeline of novel preclinical ADCs and mAbs focused on oncologic indications with significant unmet medical needs.

    List your booth number for exhibitions, ask us